Keyword: RMTC

  • Stanley Bergstein Award

    Writing Award Prize Benefits RMTC

    The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.

  • RMTC Board Names Interim Director

    At its April 23 meeting the Racing Medication and Testing Consortium board of directors approved an agreement with The Jockey Club to engage the full-time services of Jamie Haydon as RMTC interim executive director.

  • Waterman Named Arizona Racing Adviser

    Dr. Scot Waterman, most recently executive director of the Racing Medication and Testing Consortium, has been hired as the first animal medication and welfare adviser for the Arizona Department of Racing.

  • No Salix in Graded Stakes for 2YOs in 2012

    The American Graded Stakes Committee said Aug. 10 it will employ a pilot program that will ban race-day medications -- primarily the anti-bleeding drug Salix -- in graded 2-year-old stakes in 2012.

  • RMTC: Tighten Salix Rules, Ban Adjunct Drugs

    An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.

  • Officials Confirm International Drug Summit

    As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.

  • International Drug Summit Said to Be Planned

    Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.

  • Sources: Waterman Leaving Post at RMTC

    Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.

  • RCI: Phase Out Use of Drugs in Five Years

    In an announcement that could meet with disagreement with some horsemen's groups and perhaps others, the Association of Racing Commissioners International has called for a five-year phase-out of equine medication in racing.

  • Officials Cite Progress Made in Drug Testing

    Laboratories that test samples for the presence of drugs in California, Delaware, Kentucky, New York, Pennsylvania, West Virginia, and other states have signed letters of intent to submit to accreditation.

  • Racing Industry Gets Congressional Inquiry

    U.S. Sen. Tom Udall and U.S. Rep. Ed Whitfield requested detailed answers on the progress of drug testing and monitoring and racetrack safety from industry leaders.

  • RMTC Acts to Reduce Potential Impact of Bute

    The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.

  • Drug Testing Task Force to Be Formed

    Moving forward with its initiative to significantly change the structure of drug testing in U.S. horse racing, the Racing Medication and Testing Consortium (RMTC) board of directors has approved the formation of a committee to oversee the implementation of the Drug Testing Initiative (DTI) Task Force recommendations on quality assurance and laboratory accreditation programs for U.S. horse racing drug testing laboratories.

  • Possible Change in Drug Rules Questioned

    The Association of Racing Commissioners International is looking at extending the cutoff time for use of non-steroidal anti-inflammatory drugs in racehorses beyond 24 hours prior to a race, but horsemen's groups claim the action is premature.

  • RMTC Board Approves New Testing Standards

    The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.

  • Horsemen, Chemist: Drug Problem Exaggerated

    The National Horsemen's Benevolent and Protective Association said July 1 it plans to be more involved as the racing industry considers medication and drug-testing policies horsemen believe could be detrimental and counterproductive.

  • Changes Ahead for Drug-Testing Protocol

    The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.

  • New Targets for Medication Regulation

    Though most racing jurisdictions in North America have greatly curtailed the use of race-day medication, two drugs commonly used in racehorses are getting a hard look from industry officials.

  • Frozen-Sample Drug Tests Get Funding

    The Jockey Club Thoroughbred Safety Committee said Feb. 11 it will fund a Racing Medication and Testing Consortium frozen-sample and retrospective testing program that will begin in April.

  • KY Officials Vow to Regulate Steroids

    Kentucky racing officials said they intend on having regulations for use of anabolic steroids in racehorses in place as quickly as possible, but discussion and research are still needed.

  • CHRB: Trainers Should Stop Steroids Now

    If your horse is being treated with anabolic steroids and you plan to race in California, the time to stop administering them is now. That's the word from Richard Shapiro, chairman of the California Horse Racing Board, and Dr. Rick Arthur, the agency's equine medical director.

  • RMTC Strives for Uniform Drug Testing

    The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.